Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prophylaxis of Avian Influenza”

24 trials

Showing 20 of 24 results

Early research (Phase 1)Study completedNCT00922259
What this trial is testing

Safety and Immunogenicity of Live Influenza A Vaccine for Avian Influenza H7N7

Who this might be right for
Influenza A
National Institute of Allergy and Infectious Diseases (NIAID) 25
Early research (Phase 1)Study completedNCT03745274
What this trial is testing

Two Doses of GHB04L1 for Pandemic Influenza Prophylaxis in Healthy Adults

Who this might be right for
Influenza, Avian
AVIR Green Hills Biotechnology AG 36
Early research (Phase 1)Study completedNCT00776711
What this trial is testing

Vaccine for Prevention of Bird Flu

Who this might be right for
Influenza, Human
National Institute of Allergy and Infectious Diseases (NIAID) 60
Large-scale testing (Phase 3)Study completedNCT01382329
What this trial is testing

H5N1 Vaccine Study in Japanese Adults

Who this might be right for
H5N1 Influenza
Alachua Government Services, Inc. 340
Testing effectiveness (Phase 2)Study completedNCT00478816
What this trial is testing

Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Adults Unprimed and Primed With Adjuvanted or Non-adjuvanted Influenza Vaccines

Who this might be right for
Prophylaxis of Avian Influenza Vaccine
Novartis Vaccines 58
Not applicableWithdrawnNCT00640874
What this trial is testing

A Prospective Study to Examine the Effectiveness and Safety of Antivirals in Volunteers Who Receive Short-term Prophylaxis Against Pandemic Influenza

Who this might be right for
Pandemic Influenza
Kirby Institute
Early research (Phase 1)Study completedNCT02151344
What this trial is testing

Evaluating the Safety and Immune Response to a Live H7N9 Influenza Virus Vaccine Followed by an Inactivated H7N9 Influenza Virus Vaccine, Given at Varying Intervals

Who this might be right for
Influenza A Virus, H7N9 Subtype
National Institute of Allergy and Infectious Diseases (NIAID) 100
Early research (Phase 1)Study completedNCT00660257
What this trial is testing

Safety and Immunogenicity of Booster Dose of An Inactivated,Adjuvanted Whole-Virion Pandemic Influenza(H5N1)Vaccine

Who this might be right for
Pandemic Influenza VaccinePreventionPandemic Influenza
Sinovac Biotech Co., Ltd 57
Testing effectiveness (Phase 2)Study completedNCT00620815
What this trial is testing

Safety and Immunogenicity of Two Doses of a Tetravalent Influenza Vaccine in Adults Aged 18 Years and Above

Who this might be right for
Influenza
Novartis Vaccines 601
Early research (Phase 1)Study completedNCT01086657
What this trial is testing

An Open-Label, Randomized Phase I Study in Healthy Adults of the Safety and Immunogenicity of Prime-Boost Intervals With Monovalent Influenza Subunit Virion (H5N1) Vaccine, A/Indonesia/05/2005 (Sanofi Pasteur, Inc.) Administered Alone or Following Re...

Who this might be right for
Influenza A Virus, H5N1 Subtype
National Institute of Allergy and Infectious Diseases (NIAID) 64
Early research (Phase 1)Study completedNCT00380237
What this trial is testing

Safety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults (Study B)

Who this might be right for
InfluenzaVirus Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 20
Early research (Phase 1)Study completedNCT00516035
What this trial is testing

Single Group Study of the Safety of and Immune Response to a Bird Flu Vaccine (H7N3) in Healthy Adults

Who this might be right for
InfluenzaVirus Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 22
Early research (Phase 1)Study completedNCT00347672
What this trial is testing

Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults

Who this might be right for
InfluenzaVirus Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 42
Not applicableWithdrawnNCT00640211
What this trial is testing

A Prospective Study to Examine the Effectiveness and Safety of Neuraminidase Inhibitors in Volunteers Who Receive Long-term Prophylaxis Against Pandemic Influenza: PIPET B

Who this might be right for
Pandemic Influenza
Kirby Institute
Early research (Phase 1)Study completedNCT00734175
What this trial is testing

Safety of and Immune Response to Recombinant Live-Attenuated Influenza H6N1 Virus Vaccine Vaccine

Who this might be right for
InfluenzaVirus Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 22
Early research (Phase 1)Study completedNCT00488046
What this trial is testing

Single Group Study of the Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults

Who this might be right for
InfluenzaVirus Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 16
Early research (Phase 1)Study completedNCT01698060
What this trial is testing

Immunogenicity of ND1.1 by Delivery Directly to the Ileum

Who this might be right for
Avian Influenza
Vaxart 12
Early research (Phase 1)Study completedNCT00110279
What this trial is testing

Safety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults (Study A)

Who this might be right for
InfluenzaVirus Diseases
National Institute of Allergy and Infectious Diseases (NIAID) 30
Early research (Phase 1)Study completedNCT01995695
What this trial is testing

Safety and Immunogenicity of a Live Attenuated H7N9 Influenza Virus Vaccine in Healthy Adults

Who this might be right for
Influenza A Virus, H7N9 Subtype
National Institute of Allergy and Infectious Diseases (NIAID) 48
Early research (Phase 1)Study completedNCT00309647
What this trial is testing

Study to Evaluate the Safety and Immunogenicity of Pandemic Monovalent (H5N1) Influenza Vaccines (Whole Virus Formulation) in Adults 18 and 60 Years of Age

Who this might be right for
Influenza
GlaxoSmithKline 400
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation